Davis's Drug Guide
vanzacaftor/tezacaftor/deutivacaftor
General
Genetic Implications:
Pronunciation:
van-zah-kaf-tor/tez-a-kaf-tor/due-tiv-a-kaf-tor
Trade Name(s)
- Alyftrek
Ther. Class.
cystic fibrosis therapy adjuncts
Pharm. Class.
transmembrane conductance regulator potentiators
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Vanzacaftor/tezacaftor/deutivacaftor." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor.
Vallerand AHA, Sanoski CAC, . Vanzacaftor/tezacaftor/deutivacaftor. Davis's Drug Guide. F.A. Davis Company; 2025. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor. Accessed October 17, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Vanzacaftor/tezacaftor/deutivacaftor. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor
Vallerand AHA, Sanoski CAC, . Vanzacaftor/tezacaftor/deutivacaftor [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 17]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - vanzacaftor/tezacaftor/deutivacaftor
ID - 3580143
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor
PB - F.A. Davis Company
ET - 19
DB - Pediatrics Central
DP - Unbound Medicine
ER -
